REVBW (STOCKS)
Revelation Biosciences, Inc. Warrant
$0.009100
+0.000800 (+9.64%)
Prev close: $0.008300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James M. Rolke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 9
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $157.17K |
| Operating Expenses | $9.07M |
| Research and Development | $4.06M |
| Other Operating Expenses | $5.01M |
| Operating Income/Loss | -$9.07M |
| Income/Loss From Continuing Operations After Tax | -$8.91M |
| Income/Loss From Continuing Operations Before Tax | -$8.91M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$8.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.95M |
| Preferred Stock Dividends And Other Adjustments | $5.95M |
| Basic Earnings Per Share | -$23.95 |
| Diluted Earnings Per Share | -$23.95 |
| Basic Average Shares | 620,785 |
| Diluted Average Shares | 620,785 |
| Assets | $11.58M |
| Current Assets | $10.81M |
| Noncurrent Assets | $771.30K |
| Fixed Assets | $18.07K |
| Other Non-current Assets | $753.23K |
| Liabilities | $2.72M |
| Current Liabilities | $2.00M |
| Accounts Payable | $577.50K |
| Other Current Liabilities | $1.42M |
| Noncurrent Liabilities | $723.77K |
| Equity | $8.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.86M |
| Liabilities And Equity | $11.58M |
| Net Cash Flow From Operating Activities | -$8.27M |
| Net Cash Flow From Operating Activities, Continuing | -$8.27M |
| Net Cash Flow From Investing Activities | -$4.20M |
| Net Cash Flow From Investing Activities, Continuing | -$4.20M |
| Net Cash Flow From Financing Activities | $12.47M |
| Net Cash Flow From Financing Activities, Continuing | $12.47M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.91M |
| Other Comprehensive Income/Loss | $0.00 |